BioMed Central | Articles which cite: Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.
Pawitan Y, Bjöhle J, Amler L, Borg AL, Egyhazi S, Hall P, Han X, Holmberg L, Huang F, Klaar S, Liu ET, Miller L, Nordgren H, Ploner A, Sandelin K, Shaw PM, Smeds J, Skoog L, Wedrén S, Bergh J
Breast Cancer Res 2005, 7:R953-64
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Letrozole in the neoadjuvant setting: the P024 trial. Ellis MJ, Ma C Breast Cancer Res Treat 2007, 105 Suppl 1:33-43 [PubMed Central] [PubMed] [Related articles]
2.	Filtering genes to improve sensitivity in oligonucleotide microarray data analysis. Calza S, Raffelsberger W, Ploner A, Sahel J, Leveillard T, Pawitan Y Nucleic Acids Res 2007, 35:e102 [PubMed Central] [PubMed] [Related articles]
3.	A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Yu J, Yu J, Cordero KE, Johnson MD, Ghosh D, Rae JM, Chinnaiyan AM, Lippman ME Neoplasia 2008 Jan, 10:79-88 [PubMed Central] [PubMed] [Related articles]
4.	An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Hallstrom TC, Mori S, Nevins JR Cancer Cell 2008 Jan, 13:11-22 [PubMed Central] [PubMed] [Related articles]
5.	Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer. Anjomshoaa A, Lin YH, Black MA, McCall JL, Humar B, Song S, Fukuzawa R, Yoon HS, Holzmann B, Friederichs J, van Rij A, Thompson-Fawcett M, Reeve AE Br J Cancer 2008 Sep 16, 99:966-73 [PubMed Central] [PubMed] [Related articles]
6.	Genomic signatures of breast cancer metastasis. Urquidi V, Goodison S Cytogenet Genome Res 2007, 118:116-29 [PubMed Central] [PubMed] [Related articles]
7.	The genomic analysis of lactic acidosis and acidosis response in human cancers. Chen JL, Lucas JE, Schroeder T, Mori S, Wu J, Nevins J, Dewhirst M, West M, Chi JT PLoS Genet 2008 Dec, 4:e1000293 [PubMed Central] [PubMed] [Related articles]
8.	TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus database. Lopez F, Textoris J, Bergon A, Didier G, Remy E, Granjeaud S, Imbert J, Nguyen C, Puthier D PLoS One 2008, 3:e4001 [PubMed Central] [PubMed] [Related articles]
9.	Cross-study projections of genomic biomarkers: an evaluation in cancer genomics. Lucas JE, Carvalho CM, Chen JL, Chi JT, West M PLoS One 2009, 4:e4523 [PubMed Central] [PubMed] [Related articles]
10.	Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup. Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ PLoS One 2009, 4:e4710 [PubMed Central] [PubMed] [Related articles]
11.	Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. Gyorffy B, Molnar B, Lage H, Szallasi Z, Eklund AC PLoS One 2009, 4:e5645 [PubMed Central] [PubMed] [Related articles]
12.	Dicer, Drosha, and outcomes in patients with ovarian cancer. Merritt WM, Lin YG, Han LY, Kamat AA, Spannuth WA, Schmandt R, Urbauer D, Pennacchio LA, Cheng JF, Nick AM, Deavers MT, Mourad-Zeidan A, Wang H, Mueller P, Lenburg ME, Gray JW, Mok S, Birrer MJ, Lopez-Berestein G, Coleman RL, Bar-Eli M, Sood AK N Engl J Med 2008 Dec 18, 359:2641-50 [PubMed Central] [PubMed] [Related articles]
13.	Prediction of breast cancer metastasis by genomic profiling: where do we stand? Pfeffer U, Romeo F, Noonan DM, Albini A Clin Exp Metastasis 2009, 26:547-58 [PubMed Central] [PubMed] [Related articles]
14.	RCP is a human breast cancer-promoting gene with Ras-activating function. Zhang J, Liu X, Datta A, Govindarajan K, Tam WL, Han J, George J, Wong C, Ramnarayanan K, Phua TY, Leong WY, Chan YS, Palanisamy N, Liu ET, Karuturi KM, Lim B, Miller LD J Clin Invest 2009 Aug, 119:2171-83 [PubMed Central] [PubMed] [Related articles]
15.	Utilization of genomic signatures to identify phenotype-specific drugs. Mori S, Chang JT, Andrechek ER, Potti A, Nevins JR PLoS One 2009, 4:e6772 [PubMed Central] [PubMed] [Related articles]
16.	Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. McCoy EL, Iwanaga R, Jedlicka P, Abbey NS, Chodosh LA, Heichman KA, Welm AL, Ford HL J Clin Invest 2009 Sep, 119:2663-77 [PubMed Central] [PubMed] [Related articles]
17.	The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Barón AE, Harrell JC, Horwitz KB, Billheimer D, Heichman KA, Welm AL, Schiemann WP, Ford HL J Clin Invest 2009 Sep, 119:2678-90 [PubMed Central] [PubMed] [Related articles]
18.	Can survival prediction be improved by merging gene expression data sets? Yasrebi H, Sperisen P, Praz V, Bucher P PLoS One 2009, 4:e7431 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 24 articles in BioMed Central

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us